Ingenol Mebutate Gel for Actinic Keratosis

2012464 citationsJournal Articlebronze Open Access

Authors

Mark Lebwohl · Icahn School of Medicine at Mount Sinai

Neil A. Swanson · Oregon Health & Science University

Lawrence L. Anderson

Anita E. Melgaard · Leo Pharma (Denmark)

Zhenyi Xu · Leo Pharma (Denmark)

Brian Berman · University of Miami

Abstract

Ingenol mebutate gel applied topically for 2 to 3 days is effective for field treatment of actinic keratoses. (Funded by LEO Pharma; ClinicalTrials.gov numbers, NCT00742391, NCT00916006, NCT00915551, and NCT00942604.).

Topics & Keywords

Nonmelanoma Skin Cancer Studies Cancer and Skin Lesions Cutaneous lymphoproliferative disorders research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 366, Issue 11, pp. 1010-1019

DOI: 10.1056/nejmoa1111170

Field-Weighted Citation Impact: 33.61